Company Filing History:
Years Active: 2008-2017
Title: Jan Rothenburger: Innovator in Pharmaceutical Compositions
Introduction
Jan Rothenburger is a notable inventor based in Oslip, Austria. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compositions related to tolperisone. With a total of six patents to his name, Rothenburger's work has the potential to impact therapeutic practices significantly.
Latest Patents
Rothenburger's latest patents include innovative methods and compositions involving tolperisone. One of his patents focuses on tolperisone, or a pharmaceutically acceptable salt or hydrate thereof, with 10 ppm 2-methyl-1-(4-methylphenyl)-propenone (4-MMPPO) or less. This patent outlines methods of producing tolperisone while limiting exposure to tolerable levels of 4-MMPPO. Another significant patent details methods of administering tolperisone to subjects in need, emphasizing the importance of minimizing exposure to 4-MMPPO during treatment.
Career Highlights
Rothenburger is currently associated with Sanochemia Pharmazeutika AG, where he continues to advance his research and development efforts. His work in the pharmaceutical industry has been instrumental in creating safer and more effective treatment options for patients.
Collaborations
Rothenburger collaborates with esteemed colleagues such as Stefan Welzig and Klaus Gerdes. Their combined expertise contributes to the innovative environment at Sanochemia Pharmazeutika AG.
Conclusion
Jan Rothenburger is a prominent figure in the pharmaceutical industry, known for his innovative work on tolperisone compositions. His contributions through patents and collaborations highlight his commitment to improving therapeutic methods.